Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Tsuda

Showing results (441-450 of 460) with videos related to

Pageof 46
Sort By:
Cancer|February 28, 2022
A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort studyTomo Osako, Masaaki Matsuura, Daisuke Yotsumoto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 14, 2013
64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancerKenji Tamura, Hiroaki Kurihara, Kan Yonemori, et al.
Gynecologic Oncology|November 9, 2017
Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective studyMitsuya Ishikawa, Takahiro Kasamatsu, Hitoshi Tsuda, et al.
Clinical and Experimental Immunology|June 25, 2024
Chronic skin damage induces small intestinal damage via IL-13-induced apoptosisRina Tanemoto, Masaaki Higashiyama, Akira Tomioka, et al.
Gynecologic Oncology|October 23, 2019
A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypesMitsuya Ishikawa, Takahiro Kasamatsu, Hitoshi Tsuda, et al.
Breast Cancer (Tokyo, Japan)|May 25, 2025
Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational studyShigeru Imoto, Hiroyuki Yasojima, Takeshi Nagashima, et al.
Breast Cancer (Tokyo, Japan)|March 3, 2024
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice GuidelinesMasaya Hattori, Naoko Honma, Shigenori Nagai, et al.
Neurobiology of Disease|June 20, 2024
Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's diseaseToshiki Tezuka, Mayu Ishiguro, Daisuke Taniguchi, et al.
Breast Cancer Research and Treatment|August 21, 2020
Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based studyRin Ogiya, Naoki Niikura, Hiraku Kumamaru, et al.
Biomarker Research|October 30, 2021
Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patientsTakahiro Einama, Yoji Yamagishi, Yasuhiro Takihata, et al.
Pageof 46

Showing results (441-450 of 460) with videos related to

Sort By:
Pageof 46
Cancer|February 28, 2022
A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort studyTomo Osako, Masaaki Matsuura, Daisuke Yotsumoto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 14, 2013
64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancerKenji Tamura, Hiroaki Kurihara, Kan Yonemori, et al.
Gynecologic Oncology|November 9, 2017
Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective studyMitsuya Ishikawa, Takahiro Kasamatsu, Hitoshi Tsuda, et al.
Clinical and Experimental Immunology|June 25, 2024
Chronic skin damage induces small intestinal damage via IL-13-induced apoptosisRina Tanemoto, Masaaki Higashiyama, Akira Tomioka, et al.
Gynecologic Oncology|October 23, 2019
A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypesMitsuya Ishikawa, Takahiro Kasamatsu, Hitoshi Tsuda, et al.
Breast Cancer (Tokyo, Japan)|May 25, 2025
Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational studyShigeru Imoto, Hiroyuki Yasojima, Takeshi Nagashima, et al.
Breast Cancer (Tokyo, Japan)|March 3, 2024
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice GuidelinesMasaya Hattori, Naoko Honma, Shigenori Nagai, et al.
Neurobiology of Disease|June 20, 2024
Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's diseaseToshiki Tezuka, Mayu Ishiguro, Daisuke Taniguchi, et al.
Breast Cancer Research and Treatment|August 21, 2020
Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based studyRin Ogiya, Naoki Niikura, Hiraku Kumamaru, et al.
Biomarker Research|October 30, 2021
Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patientsTakahiro Einama, Yoji Yamagishi, Yasuhiro Takihata, et al.
Pageof 46